No abstract available
Keywords:
belimumab; hypocomplementemic urticarial vasculitis; systemic lupus erythematosus; urticarial vasculitis; vasculitis.
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Humans
-
Lupus Erythematosus, Systemic* / complications
-
Lupus Erythematosus, Systemic* / drug therapy
-
Urticaria* / drug therapy
-
Urticaria* / etiology
-
Vasculitis* / drug therapy
Substances
-
belimumab
-
Antibodies, Monoclonal, Humanized